Harbin Gloria Pharmaceuticals (002437.SZ) repurchased 23.30 million shares for approximately 57.65 million yuan for the first time.
Yuheng Pharmaceutical (002437.SZ) announced that on March 10, 2025, the company successfully completed its first share repurchase through a dedicated fund...
Harbin Gloria Pharmaceuticals (002437.SZ) announced that on March 10, 2025, the company conducted its first share buyback through a special securities account using the centralized bidding method to repurchase 23.30 million shares, accounting for 1.02% of the total share capital. The highest transaction price for the first buyback of shares was 2.51 yuan per share, and the lowest transaction price was 2.44 yuan per share, with a total amount of funds used being 57.65 million yuan.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


